share_log

Eiger BioPharmaceuticals | SC 13D: Statement of acquisition of beneficial ownership by individuals-Richard Kayne(11.51%),Propel Bio Management LLC(9.86%), etc.

Eiger BioPharmaceuticals | SC 13D: Statement of acquisition of beneficial ownership by individuals-Richard Kayne(11.51%),Propel Bio Management LLC(9.86%), etc.

Eiger BioPharmaceuticals | SC 13D:超过5%持股股东披露文件-Richard Kayne(11.51%),Propel Bio Management LLC(9.86%)等
美股sec公告 ·  2023/10/20 16:29
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息